The major focus of the 2012 Stockholm meeting will be on new targets and drugs for the treatment of Alzheimer's disease. The World's leaders in the field will discuss new trial designs, animal models, neuroimaging including PET and diagnostic recommendations as well as CSF and blood markers. Emerging Novel Therapeutic Targets will be presented. Approximately 1500 participants are expected, mostly neurologists, psychiatrists, geriatricians and pharmacologists.